T cells in health and disease

L Sun, Y Su, A Jiao, X Wang, B Zhang - Signal transduction and …, 2023 - nature.com
T cells are crucial for immune functions to maintain health and prevent disease. T cell
development occurs in a stepwise process in the thymus and mainly generates CD4+ and …

The tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group

K El Bairi, HR Haynes, E Blackley, S Fineberg… - NPJ breast …, 2021 - nature.com
The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly
improved survival in several cancer settings. A subgroup of women with breast cancer (BC) …

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity

G Noël, ML Fontsa, S Garaud… - The Journal of …, 2021 - Am Soc Clin Investig
We previously demonstrated that tumor-infiltrating lymphocytes (TIL) in human breast cancer
sometimes form organized tertiary lymphoid structures (TLS) characterized by CXCL13 …

[HTML][HTML] Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer

S Garaud, L Buisseret, C Solinas, C Gu-Trantien… - JCI insight, 2019 - ncbi.nlm.nih.gov
Tumor-infiltrating B cells (TIL-B) in breast cancer (BC) have previously been associated with
improved clinical outcomes; however, their roles in tumor immunity are not currently well …

The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies

CN Baxevanis, SP Fortis, SA Perez - Seminars in cancer biology, 2021 - Elsevier
Cancer evolution is a complex process influenced by genetic factors and extracellular stimuli
that trigger signaling pathways to coordinate the continuous and dynamic interaction …

[HTML][HTML] Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity

S Verdura, E Cuyàs, E Cortada, J Brunet… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
New strategies to block the immune evasion activity of programmed death ligand-1 (PD-L1)
are urgently needed. When exploring the PD-L1-targeted effects of mechanistically diverse …

T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy

S Garaud, MC Dieu-Nosjean, K Willard-Gallo - Nature communications, 2022 - nature.com
Tumor-infiltrating lymphocytes (TILs) are critical in the elimination of cancer cells, a concept
highlighted by recent advances in cancer immunotherapy. Significant evidence reveals that …

Tertiary lymphoid structures in cancer: the double-edged sword role in antitumor immunity and potential therapeutic induction strategies

W Kang, Z Feng, J Luo, Z He, J Liu, J Wu… - Frontiers in …, 2021 - frontiersin.org
The complex tumor microenvironment (TME) plays a vital role in cancer development and
dramatically determines the efficacy of immunotherapy. Tertiary lymphoid structures (TLSs) …

TIM-3 in leukemia; immune response and beyond

M Rezaei, J Tan, C Zeng, Y Li… - Frontiers in …, 2021 - frontiersin.org
T cell immunoglobulin and mucin domain 3 (TIM-3) expression on malignant cells has been
reported in some leukemias. In myelodysplastic syndrome (MDS), increased TIM-3 …

DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary …

V Sasidharan Nair, H El Salhat, RZ Taha, A John… - Clinical …, 2018 - Springer
Background High expression of immune checkpoints in tumor microenvironment plays
significant roles in inhibiting anti-tumor immunity, which is associated with poor prognosis …